Role of the E3 ubiquitin ligase gene related to anergy in lymphocytes in glucose and lipid metabolism in the liver

Journal of Molecular Endocrinology

Volumn 42, Issue 2, 2009, Pages 161-169

  Nakamichi, Sachie ^a   Senga, Yoko ^a   Inoue, Hiroshi ^b   Emi, Aki ^a   Matsuki, Yasushi ^c   Watanabe, Eijiro ^c   Hiramatsu, Ryuji ^c   Ogawa, Wataru ^a   Kasuga, Masato ^a,d  

^a KOBE UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b KANAZAWA UNIVERSITY   (Japan)

^c DAINIPPON SUMITOMO PHARMA CO LTD   (Japan)

^d NATIONAL CENTER FOR GLOBAL HEALTH AND MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOVIRUS VECTOR; CHOLESTEROL; FATTY ACID; GENE RELATED TO ANERGY IN LYMPHOCYTE PROTEIN; GLUCOSE; GLUCOSE 6 PHOSPHATASE; INSULIN; MESSENGER RNA; MUTANT PROTEIN; PROTEIN GRAIL; SHORT HAIRPIN RNA; STEROL REGULATORY ELEMENT BINDING PROTEIN 1; TRIACYLGLYCEROL; UBIQUITIN PROTEIN LIGASE E3; UNCLASSIFIED DRUG; GRAIL PROTEIN; SMALL INTERFERING RNA; UBIQUITIN PROTEIN LIGASE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; FATTY ACID BLOOD LEVEL; GENE EXPRESSION; GLUCOSE BLOOD LEVEL; GLUCOSE INTOLERANCE; GLUCOSE METABOLISM; INSULIN BLOOD LEVEL; LIPID METABOLISM; LIVER METABOLISM; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEPLETION; TISSUE DISTRIBUTION; TRIACYLGLYCEROL BLOOD LEVEL; VIRAL GENE DELIVERY SYSTEM; ANIMAL; ANTIBODY SPECIFICITY; CLONAL ANERGY; ENZYMOLOGY; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENETICS; IMMUNOLOGY; LIVER; LYMPHOCYTE; METABOLISM;

ANIMALS; CLONAL ANERGY; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GLUCOSE; LIPID METABOLISM; LIVER; LYMPHOCYTES; MICE; ORGAN SPECIFICITY; RNA, MESSENGER; RNA, SMALL INTERFERING; UBIQUITIN-PROTEIN LIGASES;

EID: 64149102620     PISSN: 09525041     EISSN: 14796813     Source Type: Journal    
DOI: 10.1677/JME-08-0145     Document Type: Article

References (34)

1. Anandasabapathy N, Ford GS, Bloom D, Holness C, Paragas V, Seroogy C, Skrenta H, Hollenhorst M, Fathman CG & Soares L 2003 GRAIL: an E3 ubiquitin ligase that inhibits cytokine gene transcription is expressed in anergic CD4+T cells. Immunity 18 535-547.
2. Cao G, Liang Y, Broderick CL, Oldham BA, Beyer TP, Schmidt RJ, Zhang Y, Stayrook KR, Suen C, Otto KA et al. 2003 Antidiabetic action of a liver X receptor agonist mediated by inhibition of hepatic gluconeogenesis. Journal of Biological Chemistry 278 1131-1136.
3. Chen J, Halappanavar S, Th'ng JP & Li Q 2007 Ubiquitin-dependent distribution of the transcriptional coactivator p300 in cytoplasmic inclusion bodies. Epigenetics 2 92-99.
4. DeFronzo RA 2004 Pathogenesis of type 2 diabetes mellitus. Medical Clinics of North America 88 787-835.
5. Dentin R, Liu Y, Koo SH, Hedrick S, Vargas T, Heredia J, Yates J III & Montminy M 2007 Insulin modulates gluconeogenesis by inhibition of the coactivator TORC2. Nature 449 366-369.
6. Gross DN, van den Heuvel AP & Birnbaum MJ 2008 The role of FoxO in the regulation of metabolism. Oncogene 27 2320-2336.
7. Heissmeyer V, Macian F, Im SH, Varma R, Feske S, Venuprasad K, Gu H, Liu YC, Dustin ML & Rao A 2004 Calcineurin imposes T cell unresponsiveness through targeted proteolysis of signaling proteins. Nature Immunology 5 255-265.
8. Herzig S, Long F, Jhala US, Hedrick S, Quinn R, Bauer A, Rudolph D, Schutz G, Yoon C, Puigserver P et al. 2001 CREB regulates hepatic gluconeogenesis through the coactivator PGC-1. Nature 413 179-183.
9. Huang H, Regan KM, Wang F, Wang D, Smith DI, van Deursen JM & Tindall DJ 2005 Skp2 inhibits FOXO1 in tumor suppression through ubiquitin-mediated degradation. PNAS 102 1649-1654.
10. Inoue H, Ogawa W, Asakawa A, Okamoto Y, Nishizawa A, Matsumoto M, Teshigawara K, Matsuki Y, Watanabe E, Hiramatsu R et al. 2006 Role of hepatic STAT3 in brain-insulin action on hepatic glucose production. Cell Metabolism 3 267-275.
11. Kato S, Ding J, Psick E, Jhala US & Du K 2008 COP1 functions as a FoxO1 ubiquitin E3 ligase to regulate FoxO1-mediated gene expression. Journal of Biological Chemistry 283 35464-35473.
12. Kim YD, Park KG, Lee YS, Park YY, Kim DK, Nedumaran B, Jang WG, Cho WJ, Ha J, Lee IK et al. 2008 Metformin inhibits hepatic gluconeogenesis through AMP-activated protein kinase-dependent regulation of the orphan nuclear receptor SHP. Diabetes 57 306-314.
13. Kitamura T, Kitamura Y, Kuroda S, Hino Y, Ando M, Kotani K, Konishi H, Matsuzaki H, Kikkawa U, Ogawa W et al. 1999 Insulin-induced phosphorylation and activation of cyclic nucleotide phosphodiesterase 3B by the serine-threonine kinase Akt. Molecular and Cellular Biology 19 6286-6296.
14. Koo SH, Satoh H, Herzig S, Lee CH, Hedrick S, Kulkarni R, Evans RM, Olefsky J & Montminy M 2004 PGC-1 promotes insulin resistance in liver through PPAR-α-dependent induction of TRB-3. Nature Medicine 10 530-534.
15. Koo SH, Flechner L, Qi L, Zhang X, Screaton RA, Jeffries S, Hedrick S, Xu W, Boussouar F, Brindle P et al. 2005 The CREB coactivator TORC2 is a key regulator of fasting glucose metabolism. Nature 437 1109-1111.
16. Lineberry NB, Su LL, Lin JT, Coffey GP, Seroogy CM & Fathman CG 2008a The transmembrane E3 ligase GRAIL ubiquitinates the costimulatory molecule CD40 ligand during the induction of T cell anergy. Journal of Immunology 181 1622-1626.
17. Lineberry N, Su L, Soares L & Fathman CG 2008b The single-subunit transmembrane E3 ligase GRAIL captures and then ubiquitinates transmembrane proteins across the cell membrane. Journal of Biological Chemistry 283 28497-28505.
18. Matsumoto M, Ogawa W, Akimoto K, Inoue H, Miyake K, Furukawa K, Hayashi Y, Iguchi H, Matsuki Y, Hiramatsu R et al. 2003 PKCλ in liver mediates insulin-induced SREBP-1c expression and determines both hepatic lipid content and overall insulin sensitivity. Journal of Clinical Investigation 112 935-944.
19. Miyake K, Ogawa W, Matsumoto M, Nakamura T, Sakaue H & Kasuga M 2002 Hyperinsulinemia, glucose intolerance, and dyslipidemia induced by acute inhibition of phosphoinositide 3-kinase signaling in the liver. Journal of Clinical Investigation 110 1483-1491.
20. O'Brien RM, Streeper RS, Ayala JE, Stadelmaier BT & Hornbuckle LA 2001 Insulin-regulated gene expression. Biochemical Society Transactions 29 552-558.
21. Okamoto Y, Ogawa W, Nishizawa A, Inoue H, Teshigawara K, Kinoshita S, Matsuki Y, Watanabe E, Hiramatsu R, Sakaue H et al. 2007 Restoration of glucokinase expression in the liver normalizes postprandial glucose disposal in mice with hepatic deficiency of PDK1. Diabetes 56 1000-1009.
22. Radziuk J & Pye S 2001 Hepatic glucose uptake, gluconeogenesis and the regulation of glycogen synthesis. Diabetes/Metabolism Research and Reviews 17 250-272.
23. Reynolds A, Leake D, Boese Q, Scaringe S, Marshall WS & Khvorova A 2004 Rational siRNA design for RNA interference. Nature Biotechnology 22 326-330.
24. Sano M, Tokudome S, Shimizu N, Yoshikawa N, Ogawa C, Shirakawa K, Endo J, Katayama T, Yuasa S, Ieda M et al. 2007 Intramolecular control of protein stability, subnuclear compartmentalization, and coactivator function of peroxisome proliferator-activated receptor gamma coactivator 1α. Journal of Biological Chemistry 282 25970-25980.
25. Savage DB, Petersen KF & Shulman GI 2007 Disordered lipid metabolism and the pathogenesis of insulin resistance. Physiological Reviews 87 507-520.
26. Seroogy CM, Soares L, Ranheim EA, Su L, Holness C, Bloom D & Fathman CG 2004 The gene related to anergy in lymphocytes, an E3 ubiquitin ligase, is necessary for anergy induction in CD4 T cells. Journal of Immunology 173 79-85.
27. Shimano H 2001 Sterol regulatory element-binding proteins (SREBPs): transcriptional regulators of lipid synthetic genes. Progress in Lipid Research 40 439-452.
28. Soares L, Seroogy C, Skrenta H, Anandasabapathy N, Lovelace P, Chung CD, Engleman E & Fathman CG 2004 Two isoforms of otubain 1 regulate T cell anergy via GRAIL. Nature Immunology 5 45-54.
29. Taniguchi CM, Ueki K & Kahn R 2005 Complementary roles of IRS-1 and IRS-2 in the hepatic regulation of metabolism. Journal of Clinical Investigation 115 718-727.
30. Teshigawara K, OgawaW, Mori T,Matsuki Y,Watanabe E, Hiramatsu R, Inoue H, Miyake K, Sakaue H & KasugaM2005 Role of Kruppel-like factor 15 in PEPCK gene expression in the liver. Biochemical and Biophysical Research Communications 327 920-926.
31. Trinh KY, O'Doherty RM, Anderson P, Lange AJ & Newgard CB 1998 Perturbation of fuel homeostasis caused by overexpression of the glucose-6-phosphatase catalytic subunit in liver of normal rats. Journal of Biological Chemistry 273 31615-31620.
32. Valera A, Pujol A, Pelegrin M & Bosch F 1994 Transgenic mice overexpressing phosphoenolpyruvate carboxykinase develop noninsulin-dependent diabetes mellitus. PNAS 91 9151-9154.
33. Yoon JC, Puigserver P, Chen G, Donovan J, Wu Z, Rhee J, Adelmant G, Stafford J, Kahn CR, Granner DK et al. 2001 Control of hepatic gluconeogenesis through the transcriptional coactivator PGC-1. Nature 413 131-138.
34. Zhang Y, Lee FY, Barrera G, Lee H, Vales C, Gonzalez FJ, Willson TM & Edwards PA 2006 Activation of the nuclear receptor FXR improves hyperglycemia and hyperlipidemia in diabetic mice. PNAS 103 1006-1011.